Zobrazeno 1 - 10
of 37
pro vyhledávání: '"John, Thenganatt"'
Autor:
Susanna Mak, Shimon Kolker, Natasha R. Girdharry, Robert F. Bentley, Felipe H. Valle, Vikram Gurtu, K. H. Mok, Jakov Moric, John Thenganatt, John T. Granton
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 3, Pp n/a-n/a (2022)
Abstract The spectrum of patients referred for suspected pulmonary arterial hypertension (PAH) includes a population with clinical features suggestive of pulmonary hypertension due to left heart disease (PH‐LHD). Even after right heart catheterizat
Externí odkaz:
https://doaj.org/article/d14415638e8a436cb8eaee9947615d4c
Autor:
Micheal C. McInnis, David Wang, Laura Donahoe, John Granton, John Thenganatt, Kongteng Tan, John Kavanagh, Marc de Perrot
Publikováno v:
ERJ Open Research, Vol 6, Iss 4 (2020)
Background Radiological assessment of patients with chronic thromboembolic pulmonary hypertension (CTEPH) is critical to decide whether patients should be treated with pulmonary endarterectomy (PEA). Although computed tomography pulmonary angiography
Externí odkaz:
https://doaj.org/article/e44fac60512c47c5b6bb12d6ac620305
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Pulmonary arterial hypertension is associated with tyrosine kinase inhibitors used in the treatment of chronic myeloid leukemia. Dasatinib is a known cause of drug-induced pulmonary arterial hypertension. There have been case reports linking Bosutini
Externí odkaz:
https://doaj.org/article/2338202ea3cb42d2a1ef3412365357c9
Autor:
Natalie K. Kozij, John T. Granton, Philip E. Silkoff, John Thenganatt, Shobha Chakravorty, Sindhu R. Johnson
Publikováno v:
Canadian Respiratory Journal, Vol 2017 (2017)
Background. Exhaled nitric oxide (eNO) is a potential biomarker to distinguish systemic sclerosis (SSc) associated pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD). We evaluated the discriminative validity, feasibility, metho
Externí odkaz:
https://doaj.org/article/5d63911214d84f1dbea3fa914a87a204
Autor:
Mary K. Kennedy, Sean A. Kennedy, Kong Teng Tan, Marc de Perrot, Paul Bassett, Michael C. McInnis, John Thenganatt, Laura Donahoe, John Granton, Sebastian Mafeld
Publikováno v:
Cardiovascular and interventional radiology. 46(1)
To perform a systematic review and meta-analysis assessing the safety and efficacy of balloon pulmonary angioplasty (BPA) in the treatment of chronic thromboembolic pulmonary hypertension (CTEPH).Systematic literature searches were performed from inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1575f2f0114cd291a8bff2bf5506a67
https://pubmed.ncbi.nlm.nih.gov/36474104
https://pubmed.ncbi.nlm.nih.gov/36474104
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Pulmonary Circulation
Pulmonary Circulation
Pulmonary arterial hypertension is associated with tyrosine kinase inhibitors used in the treatment of chronic myeloid leukemia. Dasatinib is a known cause of drug-induced pulmonary arterial hypertension. There have been case reports linking Bosutini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fc70516ca2031bdee7907bd90a6aac6
https://doi.org/10.1177/2045894020936913
https://doi.org/10.1177/2045894020936913
Publikováno v:
Respiratory Medicine Case Reports, Vol 13, Iss C, Pp 48-50 (2014)
Angiosarcomas are rare, malignant, endothelial-cell tumors of vascular origin that can arise at any body site. They frequently metastasize to the lung, heralded by dyspnea, hemoptysis, chest pain, pneumothoraces, and diffuse pulmonary hemorrhage. How
Externí odkaz:
https://doaj.org/article/4fd6e6b5a7714e7489b9703710278b28
Autor:
Marc, de Perrot, Karen, McRae, Laura, Donahoe, Etienne, Abdelnour-Berchtold, John, Thenganatt, John, Granton
Publikováno v:
Ann Cardiothorac Surg
BACKGROUND: Pulmonary endarterectomy (PEA) in severe chronic thromboembolic pulmonary hypertension (CTEPH) is associated with higher risks. However, recent evidence suggests that these risks may be mitigated with the use of extracorporeal membrane ox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c0d87b43df225be038057bf00619c24d
https://pubmed.ncbi.nlm.nih.gov/35433364
https://pubmed.ncbi.nlm.nih.gov/35433364
Autor:
Marc, de Perrot, Laura, Donahoe, Karen, McRae, John, Thenganatt, Jakov, Moric, Justin, Chan, Micheal, McInnis, Klaudia, Jumaa, Kong Teng, Tan, Sebastian, Mafeld, John, Granton
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 164:696-707.e4
Determine the long-term outcome and need for additional therapy after pulmonary endarterectomy (PEA) for segmental chronic thromboembolic pulmonary hypertension.Retrospective analysis of a prospective cohort of 401 consecutive Canadian patients under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a11fd4139ef949363d496d08c36e553
https://doi.org/10.1016/j.jtcvs.2021.10.078
https://doi.org/10.1016/j.jtcvs.2021.10.078
Publikováno v:
Hemodialysis International. 23:E49-E52
Pulmonary hypertension (PH) defined as a mean pulmonary arterial pressure ≥25 mmHg is a common complication in hemodialysis occurring in up to 58% of patients. PH is classified according to its etiology. We report in a patient with severe PH of mix
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f1f5b21616c3a397e9ef29cc8b1e45
https://doi.org/10.1111/hdi.12691
https://doi.org/10.1111/hdi.12691